Autism Spectrum Disorder (ASD) is a complex group of heterogeneous neurodevelopmental disorders characterized by early-onset difficulties in social communication and unusually restricted, repetitive behaviour and interests. Autism, being a complex disorder, can be caused by a combination of genetic and environmental factors. Genetic studies have revealed the involvement of hundreds of gene variants. Their risk effects are highly variable, and some of them are frequently related to other conditions besides Autism.
A rapidly growing list of rare genetic causes of ASD are being identified, giving insights
into the underlying biology of these disorders. Contrary to what is generally assumed,
existing genetic findings are already able to reform current clinical
practice. Genetic findings have a potential to improve the quality of
health care provided to individuals with an ASD and to thus improve
their quality of life.
Join us for this Webinar, where we discuss the genetics behind ASD
and how you can accurately diagnose ASD using the latest
molecular diagnostics tools and make a difference in the life of your
patients and their family.
MedGenome, leaders in genetic testing in India, is a genomics and clinical data driven diagnostics and drug discovery research company founded in 2013. With state-of-the-art Next Generation Sequencing (NGS) facility, MedGenome is one of the highest throughput NGS sequencing & CAP accredited lab for genetic testing in South Asia. MedGenome offers comprehensive diagnostic solutions to researchers, doctors and hospitals and its belief in continuous innovation has led to the development of many new genetic tests. MedGenome’s clinical, phenotypic and genomics data, provide insights into complex diseases and aid in drug discovery. MedGenome, a founding member of GenomeAsia 100K, initiated to sequence 100,000 Genomes in the Asian Population to create gene-pool data for higher research purposes.